Abstract:
To evaluate the recent curative efficacy and security of high intensity focused ultrasound (type FEP-BY01) in patients with cancer of pancreas. 40 patients with cancer of pancreas, were treated by FEP-BY01. The overall response rate was 90% (36/40) , including 20% (8/40) complete response (CR) and 70% (28/40) partial response (PR) . The inefficiency rate was 10% (4/40) The cancer pain was relieved in 80% patients (32/40) . No complications such as pancreatic juice leakage, bleeding, perforation of gastrointestinal tracts, scalding of skin in the group occurred. This study shows that HIFU is a efficacious and secure treatment for the patients with cancer of pancreas.